Effectiveness of direct immunofluorescence for diagnosing autoimmune bullous diseases: data from the Central European referral department
DIF should be performed thoughtfully at both clinical and laboratory levels, and approximately 31% of positive results should be regarded as a good outcome. To increase this percentage, specialised units should be maintained to keep up with the constant development of knowledge and experience in AIBD. Negative DIF results could also be useful in differential diagnostics of AIBD, but their percentage should be minimized.
Authors
- Magdalena Jałowska (ORCID: https://orcid.org/0000-0001-8191-7475)
- Marian Dmochowski (ORCID: https://orcid.org/0000-0002-4819-2051)
- Agnieszka Seraszek‐Jaros (ORCID: https://orcid.org/0000-0003-4787-1033)
- Maria Raptis‐Bolwach
- Justyna Gornowicz‐Porowska (ORCID: https://orcid.org/0000-0003-3106-064X)
- Monika Bowszyc‐Dmochowska (ORCID: https://orcid.org/0000-0001-8221-7622)
- Bogusz Falkowski (ORCID: https://orcid.org/0000-0002-8520-260X)
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Advances in Dermatology and Allergology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5114/ada.2025.153492
- Citations
- 1
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.47